🔎 Trials Near Me

Home › Chronic Pain › NCT07641504

A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Chronic Low Back Pain

RecruitingPhase 2

Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY4065967 for the Treatment of Chronic Low Back Pain

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

* Have a history of low back pain for at least 3 months located between the 12th thoracic vertebra and the lower gluteal folds, with or without radiation
* Have a body mass index at screening of ≤40 kilograms per meter squared (kg/m²).
* Have stable glycemic control as indicated by a glycated hemoglobin (HbA1c) less than or equal to 10 at time of screening

Exclusion Criteria:

* Are pregnant or breastfeeding
* Have used a therapeutic injection to the spine in the 3 months prior to screening
* Are using a spinal cord stimulator or dorsal root ganglion stimulator
* Have ongoing complex regional pain syndrome or other concurrent medical conditions that could interfere with the evaluation of CLBP
* Have a history of major spinal deformity, such as spondylolisthesis, spondylolysis, scoliosis, or spina bifida, that causes instability to the spine
* Have an abnormal blood pressure (BP) systolic BP is greater than 140 millimeters mercury (\>140 mm Hg) and diastolic BP\>90 mm Hg at screening • Have history or current clinically significant cardiac disease, including arrhythmia, aortic aneurysm, heart failure, current electrolyte abnormalities, or any other conditions that could predispose to arrhythmia in the judgement of the investigator

About the study

The main purpose of this study is to test the safety and efficacy of study drug for the treatment of chronic low back pain (CLBP). This trial is part of the chronic pain master protocol H0P-MC-CPMP (NCT05986292), which is a protocol to accelerate the development of new treatments for chronic pain.

What is being tested

Sponsor: Eli Lilly and Company · Participants: 150 · Started: Aug 12, 2026

Contact the study team

Official record on ClinicalTrials.gov — NCT07641504

Locations in the U.S.

AlabamaCentral Research Associates, Birmingham (Not yet recruiting)
ArizonaArizona Research Center, Phoenix
Synexus Clinical Research US, Inc., Phoenix
CaliforniaDesert Oasis Healthcare Medical Group, Palm Springs (Not yet recruiting)
Artemis Institute for Clinical Research, Riverside
Artemis Institute for Clinical Research, San Diego
ConnecticutCMR of Greater New Haven, Hamden
FloridaBradenton Research Center, Inc., Bradenton
Accel Research Sites - DeLand Clinical Research Unit, DeLand
K2 MEDICAL Research THE VILLAGES, Lady Lake
K2 Medical Research ORLANDO, Maitland
Merritt Island Medical Research, LLC, Merritt Island
New Horizon Research Center, Miami
Suncoast Research Group, Miami
Suncoast Clinical Research, Inc., New Port Richey
Renstar Medical Research, Ocala
Precision Clinical Research, Sunrise
Charter Research - Lady Lake, The Villages
Conquest Research, Winter Park
GeorgiaNorth Georgia Clinical Research, Woodstock
IllinoisNorthwestern University, Chicago
LouisianaDelRicht Research, New Orleans
MassachusettsLucida Clinical Trials, New Bedford
MedVadis Research Corporation, Waltham
MichiganGreat Lakes Research Group, Inc., Bay City
MissouriStudyMetrix Research, City of Saint Peters
Clinvest Research LLC, Springfield
New YorkRochester Clinical Research, LLC, Rochester (Not yet recruiting)
North DakotaLillestol Research, Fargo
OhioMETA Medical Research Institute, Dayton
OklahomaDelRicht Research, Tulsa
PennsylvaniaAltoona Center For Clinical Research, Duncansville
TexasFutureSearch Trials of Neurology, Austin
Re:Cognition Health - Fort Worth, Fort Worth (Not yet recruiting)
WashingtonNorthwest Clinical Research Center, Bellevue
Rainier Clinical Research Center, Renton

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.